- Home
- SRPT vs ATRC Comparison
SRPT vs ATRC Comparison
Compare SRPT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- ATRC
- Stock Information
- Founded
- SRPT 1980
- ATRC 2000
- Country
- SRPT United States
- ATRC United States
- Employees
- SRPT N/A
- ATRC N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- ATRC Medical/Dental Instruments
- Sector
- SRPT Health Care
- ATRC Health Care
- Exchange
- SRPT Nasdaq
- ATRC Nasdaq
- Market Cap
- SRPT 1.9B
- ATRC 1.7B
- IPO Year
- SRPT 1997
- ATRC 2005
- Fundamental
- Price
- SRPT $17.65
- ATRC $32.02
- Analyst Decision
- SRPT Hold
- ATRC Strong Buy
- Analyst Count
- SRPT 30
- ATRC 9
- Target Price
- SRPT $35.93
- ATRC $52.00
- AVG Volume (30 Days)
- SRPT 6.1M
- ATRC 583.5K
- Earning Date
- SRPT 11-03-2025
- ATRC 10-29-2025
- Dividend Yield
- SRPT N/A
- ATRC N/A
- EPS Growth
- SRPT N/A
- ATRC N/A
- EPS
- SRPT N/A
- ATRC N/A
- Revenue
- SRPT $2,413,715,000.00
- ATRC $518,304,999.00
- Revenue This Year
- SRPT $10.20
- ATRC $16.90
- Revenue Next Year
- SRPT N/A
- ATRC $12.29
- P/E Ratio
- SRPT N/A
- ATRC N/A
- Revenue Growth
- SRPT 47.15
- ATRC 15.80
- 52 Week Low
- SRPT $10.42
- ATRC $28.29
- 52 Week High
- SRPT $138.81
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- SRPT 38.30
- ATRC 32.67
- Support Level
- SRPT $15.08
- ATRC $30.94
- Resistance Level
- SRPT $18.80
- ATRC $37.28
- Average True Range (ATR)
- SRPT 1.40
- ATRC 1.75
- MACD
- SRPT -0.84
- ATRC -0.54
- Stochastic Oscillator
- SRPT 24.92
- ATRC 14.50
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.